Table of Contents 1 Cephalosporin Market Overview 1.1 Product Overview and Scope of Cephalosporin 1.2 Cephalosporin Segment by Type 1.2.1 Global Cephalosporin Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 First Generation 1.2.3 Second Generation 1.2.4 Third Generation 1.2.5 Fourth Generation 1.3 Cephalosporin Segment by Application 1.3.1 Cephalosporin Sales Comparison by Application: 2020 VS 2026 1.3.2 Oral 1.3.3 Injection 1.4 Global Cephalosporin Market Size Estimates and Forecasts 1.4.1 Global Cephalosporin Revenue 2015-2026 1.4.2 Global Cephalosporin Sales 2015-2026 1.4.3 Cephalosporin Market Size by Region: 2020 Versus 2026 2 Global Cephalosporin Market Competition by Manufacturers 2.1 Global Cephalosporin Sales Market Share by Manufacturers (2015-2020) 2.2 Global Cephalosporin Revenue Share by Manufacturers (2015-2020) 2.3 Global Cephalosporin Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Cephalosporin Manufacturing Sites, Area Served, Product Type 2.5 Cephalosporin Market Competitive Situation and Trends 2.5.1 Cephalosporin Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Cephalosporin Players (Opinion Leaders) 3 Cephalosporin Retrospective Market Scenario by Region 3.1 Global Cephalosporin Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Cephalosporin Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Cephalosporin Market Facts & Figures by Country 3.3.1 North America Cephalosporin Sales by Country 3.3.2 North America Cephalosporin Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Cephalosporin Market Facts & Figures by Country 3.4.1 Europe Cephalosporin Sales by Country 3.4.2 Europe Cephalosporin Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Cephalosporin Market Facts & Figures by Region 3.5.1 Asia Pacific Cephalosporin Sales by Region 3.5.2 Asia Pacific Cephalosporin Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Cephalosporin Market Facts & Figures by Country 3.6.1 Latin America Cephalosporin Sales by Country 3.6.2 Latin America Cephalosporin Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Cephalosporin Market Facts & Figures by Country 3.7.1 Middle East and Africa Cephalosporin Sales by Country 3.7.2 Middle East and Africa Cephalosporin Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Cephalosporin Historic Market Analysis by Type 4.1 Global Cephalosporin Sales Market Share by Type (2015-2020) 4.2 Global Cephalosporin Revenue Market Share by Type (2015-2020) 4.3 Global Cephalosporin Price Market Share by Type (2015-2020) 4.4 Global Cephalosporin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Cephalosporin Historic Market Analysis by Application 5.1 Global Cephalosporin Sales Market Share by Application (2015-2020) 5.2 Global Cephalosporin Revenue Market Share by Application (2015-2020) 5.3 Global Cephalosporin Price by Application (2015-2020) 6 Company Profiles and Key Figures in Cephalosporin Business 6.1 Union Chempharma 6.1.1 Corporation Information 6.1.2 Union Chempharma Description, Business Overview and Total Revenue 6.1.3 Union Chempharma Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Union Chempharma Products Offered 6.1.5 Union Chempharma Recent Development 6.2 NCPC 6.2.1 NCPC Cephalosporin Production Sites and Area Served 6.2.2 NCPC Description, Business Overview and Total Revenue 6.2.3 NCPC Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.2.4 NCPC Products Offered 6.2.5 NCPC Recent Development 6.3 Qilu Antibiotics 6.3.1 Qilu Antibiotics Cephalosporin Production Sites and Area Served 6.3.2 Qilu Antibiotics Description, Business Overview and Total Revenue 6.3.3 Qilu Antibiotics Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Qilu Antibiotics Products Offered 6.3.5 Qilu Antibiotics Recent Development 6.4 Lupin Pharmaceuticals 6.4.1 Lupin Pharmaceuticals Cephalosporin Production Sites and Area Served 6.4.2 Lupin Pharmaceuticals Description, Business Overview and Total Revenue 6.4.3 Lupin Pharmaceuticals Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Lupin Pharmaceuticals Products Offered 6.4.5 Lupin Pharmaceuticals Recent Development 6.5 Hospira 6.5.1 Hospira Cephalosporin Production Sites and Area Served 6.5.2 Hospira Description, Business Overview and Total Revenue 6.5.3 Hospira Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Hospira Products Offered 6.5.5 Hospira Recent Development 6.6 Dhanuka Laboratories 6.6.1 Dhanuka Laboratories Cephalosporin Production Sites and Area Served 6.6.2 Dhanuka Laboratories Description, Business Overview and Total Revenue 6.6.3 Dhanuka Laboratories Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Dhanuka Laboratories Products Offered 6.6.5 Dhanuka Laboratories Recent Development 6.7 Fukang 6.6.1 Fukang Cephalosporin Production Sites and Area Served 6.6.2 Fukang Description, Business Overview and Total Revenue 6.6.3 Fukang Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Fukang Products Offered 6.7.5 Fukang Recent Development 6.8 Dongying Pharmaceutical 6.8.1 Dongying Pharmaceutical Cephalosporin Production Sites and Area Served 6.8.2 Dongying Pharmaceutical Description, Business Overview and Total Revenue 6.8.3 Dongying Pharmaceutical Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Dongying Pharmaceutical Products Offered 6.8.5 Dongying Pharmaceutical Recent Development 6.9 Alkem 6.9.1 Alkem Cephalosporin Production Sites and Area Served 6.9.2 Alkem Description, Business Overview and Total Revenue 6.9.3 Alkem Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Alkem Products Offered 6.9.5 Alkem Recent Development 6.10 SALUBRIS 6.10.1 SALUBRIS Cephalosporin Production Sites and Area Served 6.10.2 SALUBRIS Description, Business Overview and Total Revenue 6.10.3 SALUBRIS Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.10.4 SALUBRIS Products Offered 6.10.5 SALUBRIS Recent Development 6.11 LIVZON 6.11.1 LIVZON Cephalosporin Production Sites and Area Served 6.11.2 LIVZON Cephalosporin Description, Business Overview and Total Revenue 6.11.3 LIVZON Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.11.4 LIVZON Products Offered 6.11.5 LIVZON Recent Development 6.12 Hetero Drugs 6.12.1 Hetero Drugs Cephalosporin Production Sites and Area Served 6.12.2 Hetero Drugs Cephalosporin Description, Business Overview and Total Revenue 6.12.3 Hetero Drugs Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Hetero Drugs Products Offered 6.12.5 Hetero Drugs Recent Development 6.13 CSPC 6.13.1 CSPC Cephalosporin Production Sites and Area Served 6.13.2 CSPC Cephalosporin Description, Business Overview and Total Revenue 6.13.3 CSPC Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.13.4 CSPC Products Offered 6.13.5 CSPC Recent Development 6.14 TEVA 6.14.1 TEVA Cephalosporin Production Sites and Area Served 6.14.2 TEVA Cephalosporin Description, Business Overview and Total Revenue 6.14.3 TEVA Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.14.4 TEVA Products Offered 6.14.5 TEVA Recent Development 6.15 Orchid Pharma 6.15.1 Orchid Pharma Cephalosporin Production Sites and Area Served 6.15.2 Orchid Pharma Cephalosporin Description, Business Overview and Total Revenue 6.15.3 Orchid Pharma Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.15.4 Orchid Pharma Products Offered 6.15.5 Orchid Pharma Recent Development 6.16 Taj Pharmaceuticals 6.16.1 Taj Pharmaceuticals Cephalosporin Production Sites and Area Served 6.16.2 Taj Pharmaceuticals Cephalosporin Description, Business Overview and Total Revenue 6.16.3 Taj Pharmaceuticals Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.16.4 Taj Pharmaceuticals Products Offered 6.16.5 Taj Pharmaceuticals Recent Development 6.17 Covalent Laboratories 6.17.1 Covalent Laboratories Cephalosporin Production Sites and Area Served 6.17.2 Covalent Laboratories Cephalosporin Description, Business Overview and Total Revenue 6.17.3 Covalent Laboratories Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.17.4 Covalent Laboratories Products Offered 6.17.5 Covalent Laboratories Recent Development 6.18 United Laboratories 6.18.1 United Laboratories Cephalosporin Production Sites and Area Served 6.18.2 United Laboratories Cephalosporin Description, Business Overview and Total Revenue 6.18.3 United Laboratories Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.18.4 United Laboratories Products Offered 6.18.5 United Laboratories Recent Development 6.19 Aurobindo 6.19.1 Aurobindo Cephalosporin Production Sites and Area Served 6.19.2 Aurobindo Cephalosporin Description, Business Overview and Total Revenue 6.19.3 Aurobindo Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.19.4 Aurobindo Products Offered 6.19.5 Aurobindo Recent Development 6.20 Wockhardt 6.20.1 Wockhardt Cephalosporin Production Sites and Area Served 6.20.2 Wockhardt Cephalosporin Description, Business Overview and Total Revenue 6.20.3 Wockhardt Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.20.4 Wockhardt Products Offered 6.20.5 Wockhardt Recent Development 6.21 LKPC 6.21.1 LKPC Cephalosporin Production Sites and Area Served 6.21.2 LKPC Cephalosporin Description, Business Overview and Total Revenue 6.21.3 LKPC Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.21.4 LKPC Products Offered 6.21.5 LKPC Recent Development 6.22 HPGC 6.22.1 HPGC Cephalosporin Production Sites and Area Served 6.22.2 HPGC Cephalosporin Description, Business Overview and Total Revenue 6.22.3 HPGC Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.22.4 HPGC Products Offered 6.22.5 HPGC Recent Development 6.23 Huafangpharm 6.23.1 Huafangpharm Cephalosporin Production Sites and Area Served 6.23.2 Huafangpharm Cephalosporin Description, Business Overview and Total Revenue 6.23.3 Huafangpharm Cephalosporin Sales, Revenue and Gross Margin (2015-2020) 6.23.4 Huafangpharm Products Offered 6.23.5 Huafangpharm Recent Development 7 Cephalosporin Manufacturing Cost Analysis 7.1 Cephalosporin Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Cephalosporin 7.4 Cephalosporin Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Cephalosporin Distributors List 8.3 Cephalosporin Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Cephalosporin Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Cephalosporin by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Cephalosporin by Type (2021-2026) 10.2 Cephalosporin Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Cephalosporin by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Cephalosporin by Application (2021-2026) 10.3 Cephalosporin Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Cephalosporin by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Cephalosporin by Region (2021-2026) 10.4 North America Cephalosporin Estimates and Projections (2021-2026) 10.5 Europe Cephalosporin Estimates and Projections (2021-2026) 10.6 Asia Pacific Cephalosporin Estimates and Projections (2021-2026) 10.7 Latin America Cephalosporin Estimates and Projections (2021-2026) 10.8 Middle East and Africa Cephalosporin Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Cephalosporin Sales (MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Cephalosporin Sales (MT) Comparison by Application: 2020 VS 2026 Table 3. Global Cephalosporin Market Size by Type (MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Cephalosporin Manufacturers Covered in This Study Table 5. Global Cephalosporin Sales (MT) by Manufacturers (2015-2020) Table 6. Global Cephalosporin Sales Share by Manufacturers (2015-2020) Table 7. Global Cephalosporin Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Cephalosporin Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Cephalosporin Average Price (USD/Kg) of Key Manufacturers (2015-2020) Table 10. Manufacturers Cephalosporin Sales Sites and Area Served Table 11. Manufacturers Cephalosporin Product Types Table 12. Global Cephalosporin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Cephalosporin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cephalosporin as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Cephalosporin Players Table 16. Global Cephalosporin Sales (MT) by Region (2015-2020) Table 17. Global Cephalosporin Sales Market Share by Region (2015-2020) Table 18. Global Cephalosporin Revenue (Million US$) by Region (2015-2020) Table 19. Global Cephalosporin Revenue Market Share by Region (2015-2020) Table 20. North America Cephalosporin Sales by Country (2015-2020) (MT) Table 21. North America Cephalosporin Sales Market Share by Country (2015-2020) Table 22. North America Cephalosporin Revenue by Country (2015-2020) (US$ Million) Table 23. North America Cephalosporin Revenue Market Share by Country (2015-2020) Table 24. Europe Cephalosporin Sales by Country (2015-2020) (MT) Table 25. Europe Cephalosporin Sales Market Share by Country (2015-2020) Table 26. Europe Cephalosporin Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Cephalosporin Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Cephalosporin Sales by Region (2015-2020) (MT) Table 29. Asia Pacific Cephalosporin Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Cephalosporin Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Cephalosporin Revenue Market Share by Region (2015-2020) Table 32. Latin America Cephalosporin Sales by Country (2015-2020) (MT) Table 33. Latin America Cephalosporin Sales Market Share by Country (2015-2020) Table 34. Latin America Cephalosporin Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Cephalosporin Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Cephalosporin Sales by Country (2015-2020) (MT) Table 37. Middle East and Africa Cephalosporin Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Cephalosporin Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Cephalosporin Revenue Market Share by Country (2015-2020) Table 40. Global Cephalosporin Sales (MT) by Type (2015-2020) Table 41. Global Cephalosporin Sales Share by Type (2015-2020) Table 42. Global Cephalosporin Revenue (Million US$) by Type (2015-2020) Table 43. Global Cephalosporin Revenue Share by Type (2015-2020) Table 44. Global Cephalosporin Price (USD/Kg) by Type (2015-2020) Table 45. Global Cephalosporin Sales (MT) by Application (2015-2020) Table 46. Global Cephalosporin Sales Market Share by Application (2015-2020) Table 47. Global Cephalosporin Sales Growth Rate by Application (2015-2020) Table 48. Union Chempharma Cephalosporin Corporation Information Table 49. Union Chempharma Description and Business Overview Table 50. Union Chempharma Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 51. Union Chempharma Main Product Table 52. Union Chempharma Recent Development Table 53. NCPC Cephalosporin Corporation Information Table 54. NCPC Corporation Information Table 55. NCPC Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 56. NCPC Main Product Table 57. NCPC Recent Development Table 58. Qilu Antibiotics Cephalosporin Corporation Information Table 59. Qilu Antibiotics Corporation Information Table 60. Qilu Antibiotics Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 61. Qilu Antibiotics Main Product Table 62. Qilu Antibiotics Recent Development Table 63. Lupin Pharmaceuticals Cephalosporin Corporation Information Table 64. Lupin Pharmaceuticals Corporation Information Table 65. Lupin Pharmaceuticals Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 66. Lupin Pharmaceuticals Main Product Table 67. Lupin Pharmaceuticals Recent Development Table 68. Hospira Cephalosporin Corporation Information Table 69. Hospira Corporation Information Table 70. Hospira Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 71. Hospira Main Product Table 72. Hospira Recent Development Table 73. Dhanuka Laboratories Cephalosporin Corporation Information Table 74. Dhanuka Laboratories Corporation Information Table 75. Dhanuka Laboratories Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 76. Dhanuka Laboratories Main Product Table 77. Dhanuka Laboratories Recent Development Table 78. Fukang Cephalosporin Corporation Information Table 79. Fukang Corporation Information Table 80. Fukang Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 81. Fukang Main Product Table 82. Fukang Recent Development Table 83. Dongying Pharmaceutical Cephalosporin Corporation Information Table 84. Dongying Pharmaceutical Corporation Information Table 85. Dongying Pharmaceutical Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 86. Dongying Pharmaceutical Main Product Table 87. Dongying Pharmaceutical Recent Development Table 88. Alkem Cephalosporin Corporation Information Table 89. Alkem Corporation Information Table 90. Alkem Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 91. Alkem Main Product Table 92. Alkem Recent Development Table 93. SALUBRIS Cephalosporin Corporation Information Table 94. SALUBRIS Corporation Information Table 95. SALUBRIS Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 96. SALUBRIS Main Product Table 97. SALUBRIS Recent Development Table 98. LIVZON Cephalosporin Corporation Information Table 99. LIVZON Corporation Information Table 100. LIVZON Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 101. LIVZON Main Product Table 102. LIVZON Recent Development Table 103. Hetero Drugs Cephalosporin Corporation Information Table 104. Hetero Drugs Corporation Information Table 105. Hetero Drugs Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 106. Hetero Drugs Main Product Table 107. Hetero Drugs Recent Development Table 108. CSPC Cephalosporin Corporation Information Table 109. CSPC Corporation Information Table 110. CSPC Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 111. CSPC Main Product Table 112. CSPC Recent Development Table 113. TEVA Cephalosporin Corporation Information Table 114. TEVA Corporation Information Table 115. TEVA Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 116. TEVA Main Product Table 117. TEVA Recent Development Table 118. Orchid Pharma Cephalosporin Corporation Information Table 119. Orchid Pharma Corporation Information Table 120. Orchid Pharma Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 121. Orchid Pharma Main Product Table 122. Orchid Pharma Recent Development Table 123. Taj Pharmaceuticals Cephalosporin Corporation Information Table 124. Taj Pharmaceuticals Corporation Information Table 125. Taj Pharmaceuticals Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 126. Taj Pharmaceuticals Main Product Table 127. Taj Pharmaceuticals Recent Development Table 128. Covalent Laboratories Cephalosporin Corporation Information Table 129. Covalent Laboratories Corporation Information Table 130. Covalent Laboratories Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 131. Covalent Laboratories Main Product Table 132. Covalent Laboratories Recent Development Table 133. United Laboratories Cephalosporin Corporation Information Table 134. United Laboratories Corporation Information Table 135. United Laboratories Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 136. United Laboratories Main Product Table 137. United Laboratories Recent Development Table 138. Aurobindo Cephalosporin Corporation Information Table 139. Aurobindo Corporation Information Table 140. Aurobindo Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 141. Aurobindo Main Product Table 142. Aurobindo Recent Development Table 143. Wockhardt Cephalosporin Corporation Information Table 144. Wockhardt Corporation Information Table 145. Wockhardt Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 146. Wockhardt Main Product Table 147. Wockhardt Recent Development Table 148. LKPC Cephalosporin Corporation Information Table 149. LKPC Corporation Information Table 150. LKPC Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 151. LKPC Main Product Table 152. LKPC Recent Development Table 153. HPGC Cephalosporin Corporation Information Table 154. HPGC Corporation Information Table 155. HPGC Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 156. HPGC Main Product Table 157. HPGC Recent Development Table 158. Huafangpharm Cephalosporin Corporation Information Table 159. Huafangpharm Corporation Information Table 160. Huafangpharm Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 161. Huafangpharm Main Product Table 162. Huafangpharm Recent Development Table 163. Sales Base and Market Concentration Rate of Raw Material Table 164. Key Suppliers of Raw Materials Table 165. Cephalosporin Distributors List Table 166. Cephalosporin Customers List Table 167. Market Key Trends Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 169. Key Challenges Table 170. Global Cephalosporin Sales (MT) Forecast by Type (2021-2026) Table 171. Global Cephalosporin Sales Market Share Forecast by Type (2021-2026) Table 172. Global Cephalosporin Revenue (Million US$) Forecast by Type (2021-2026) Table 173. Global Cephalosporin Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 174. Global Cephalosporin Sales (MT) Forecast by Application (2021-2026) Table 175. Global Cephalosporin Revenue (Million US$) Forecast by Application (2021-2026) Table 176. Global Cephalosporin Sales (MT) Forecast by Region (2021-2026) Table 177. Global Cephalosporin Sales Market Share Forecast by Region (2021-2026) Table 178. Global Cephalosporin Revenue Forecast by Region (2021-2026) (US$ Million) Table 179. Global Cephalosporin Revenue Market Share Forecast by Region (2021-2026) Table 180. Research Programs/Design for This Report Table 181. Key Data Information from Secondary Sources Table 182. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Cephalosporin Figure 2. Global Cephalosporin Sales Market Share by Type: 2020 VS 2026 Figure 3. First Generation Product Picture Figure 4. Second Generation Product Picture Figure 5. Third Generation Product Picture Figure 6. Fourth Generation Product Picture Figure 7. Global Cephalosporin Consumption Market Share by Application: 2020 VS 2026 Figure 8. Oral Figure 9. Injection Figure 10. Global Cephalosporin Market Size 2015-2026 (US$ Million) Figure 11. Global Cephalosporin Sales Capacity (MT) (2015-2026) Figure 12. Global Cephalosporin Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Cephalosporin Sales Share by Manufacturers in 2020 Figure 14. Global Cephalosporin Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Cephalosporin Revenue in 2019 Figure 16. Cephalosporin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Cephalosporin Sales Market Share by Region (2015-2020) Figure 18. Global Cephalosporin Sales Market Share by Region in 2019 Figure 19. Global Cephalosporin Revenue Market Share by Region (2015-2020) Figure 20. Global Cephalosporin Revenue Market Share by Region in 2019 Figure 21. North America Cephalosporin Sales Market Share by Country in 2019 Figure 22. North America Cephalosporin Revenue Market Share by Country in 2019 Figure 23. U.S. Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 24. U.S. Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 26. Canada Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Cephalosporin Sales Market Share by Country in 2019 Figure 28. Europe Cephalosporin Revenue Market Share by Country in 2019 Figure 29. Germany Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 30. Germany Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 32. France Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 34. U.K. Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 36. Italy Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 38. Russia Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Cephalosporin Sales Market Share by Region in 2019 Figure 40. Asia Pacific Cephalosporin Revenue Market Share by Region in 2019 Figure 41. China Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 42. China Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 44. Japan Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 46. South Korea Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 48. India Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 50. Australia Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 52. Taiwan Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 54. Indonesia Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 56. Thailand Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 58. Malaysia Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 60. Philippines Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 62. Vietnam Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Cephalosporin Sales Market Share by Country in 2019 Figure 64. Latin America Cephalosporin Revenue Market Share by Country in 2019 Figure 65. Mexico Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 66. Mexico Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 68. Brazil Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 70. Argentina Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Cephalosporin Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Cephalosporin Revenue Market Share by Country in 2019 Figure 73. Turkey Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 74. Turkey Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 76. Saudi Arabia Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Cephalosporin Sales Growth Rate (2015-2020) (MT) Figure 78. U.A.E Cephalosporin Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Cephalosporin by Type (2015-2020) Figure 80. Sales Market Share of Cephalosporin by Type in 2019 Figure 81. Revenue Share of Cephalosporin by Type (2015-2020) Figure 82. Revenue Market Share of Cephalosporin by Type in 2019 Figure 83. Global Cephalosporin Sales Growth by Type (2015-2020) (MT) Figure 84. Global Cephalosporin Sales Market Share by Application (2015-2020) Figure 85. Global Cephalosporin Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Cephalosporin by Application (2015-2020) Figure 87. Global Revenue Share of Cephalosporin by Application in 2020 Figure 88. Union Chempharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. NCPC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Qilu Antibiotics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Hospira Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Dhanuka Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Fukang Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Dongying Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Alkem Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. SALUBRIS Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. LIVZON Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Hetero Drugs Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. CSPC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. TEVA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Orchid Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Covalent Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. United Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 106. Aurobindo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 107. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018 Figure 108. LKPC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 109. HPGC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 110. Huafangpharm Total Revenue (US$ Million): 2019 Compared with 2018 Figure 111. Price Trend of Key Raw Materials Figure 112. Manufacturing Cost Structure of Cephalosporin Figure 113. Manufacturing Process Analysis of Cephalosporin Figure 114. Cephalosporin Industrial Chain Analysis Figure 115. Channels of Distribution Figure 116. Distributors Profiles Figure 117. Porter's Five Forces Analysis Figure 118. North America Cephalosporin Sales (MT) and Growth Rate Forecast (2021-2026) Figure 119. North America Cephalosporin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Europe Cephalosporin Sales (MT) and Growth Rate Forecast (2021-2026) Figure 121. Europe Cephalosporin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Latin America Cephalosporin Sales (MT) and Growth Rate Forecast (2021-2026) Figure 123. Latin America Cephalosporin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 124. Middle East and Africa Cephalosporin Sales (MT) and Growth Rate Forecast (2021-2026) Figure 125. Middle East and Africa Cephalosporin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 126. Asia Pacific Cephalosporin Sales (MT) and Growth Rate Forecast (2021-2026) Figure 127. Asia Pacific Cephalosporin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 128. Bottom-up and Top-down Approaches for This Report Figure 129. Data Triangulation Figure 130. Key Executives Interviewed

Union Chempharma NCPC Qilu Antibiotics Lupin Pharmaceuticals Hospira Dhanuka Laboratories Fukang Dongying Pharmaceutical Alkem SALUBRIS LIVZON Hetero Drugs CSPC TEVA Orchid Pharma Taj Pharmaceuticals Covalent Laboratories United Laboratories Aurobindo Wockhardt LKPC HPGC Huafangpharm